Related Experiment Video
Updated: May 12, 2026
15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
The VPS35 gene and Parkinson's disease
Hao Deng1, Kai Gao, Joseph Jankovic
1Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, China. hdeng008@yahoo.com
Summary
The vacuolar protein sorting 35 homolog (VPS35) gene is implicated in Parkinson's disease (PD) pathogenesis. Understanding VPS35, Wnt/β-catenin signaling, and iron transport by DMT1 offers new insights for PD prevention and treatment.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder affecting dopaminergic and nondopaminergic neurons, causing motor and non-motor symptoms.
- Genetic predisposition and specific gene mutations are significant factors in PD pathogenesis.
- The discovery of the vacuolar protein sorting 35 homolog (VPS35) gene, associated with autosomal dominant late-onset PD, offers new research avenues.
Purpose of the Study:
- To discuss the role of the VPS35 gene in Parkinson's disease.
- To explore the protein function of VPS35 and its involvement in cellular pathways.
- To investigate the mechanisms of Wnt/β-catenin signaling and iron transport in PD.
Main Methods:
- Review and discussion of existing literature on VPS35 gene.
- Analysis of VPS35 protein function and its relation to PD.
- Examination of Wnt/β-catenin signaling pathways and DMT1-mediated iron uptake/translocation.
Main Results:
- The VPS35 gene is identified as a key factor in the pathogenesis of autosomal dominant late-onset PD.
- VPS35 protein function is linked to cellular pathways relevant to neurodegeneration.
- DMT1 plays a role in iron uptake and translocation, potentially contributing to PD mechanisms.
Conclusions:
- Further understanding of VPS35, Wnt/β-catenin signaling, and iron metabolism (DMT1) is crucial for elucidating PD pathogenesis.
- These insights may lead to novel strategies for the prevention and treatment of Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...